SYNTHESIS AND IN VITRO AND IN VIVO EVALUATION OF [¹¹C]METHYL-BIII277CL FOR IMAGING THE PCP-BINDING SITE OF THE NMDA RECEPTOR BY PET

REFERENCES

• Kleckner N. W., Dingledine R. Requirement for Glycine in Activation of NMDA-Receptors Expressed in Xenopus Oocytes. Science 1988; 241: 835–837
   PubMed Web of Science ®Google Scholar
• Johnson J. W., Ascher P. Glycine Potentiates the NMDA Response in Cultured Mouse Brain Neurons. Nature 1987; 325: 529–531
   PubMed Web of Science ®Google Scholar
• Nowak L., Bregestovski P., Ascher P., Herbet A., Prochiantz A. Magnesium Gates Glutamate-Activated Channels in Mouse Central Neurones. Nature 1984; 307: 462–465
   PubMed Web of Science ®Google Scholar
• Johnson J. W., Ascher P. Voltage-Dependent Block by Intracellular Mg2+ of N-Methyl-D-Aspartate-Activated Channels. Biophys. J. 1990; 57: 1085–1090
   PubMedGoogle Scholar
• Collingridge G. L., Singer W. Excitatory Amino Acid Receptors and Synaptic Plasticity. Trends Pharmacol. Sci. 1990; 11: 290–296
   PubMed Web of Science ®Google Scholar
• Malenka R. C. Synaptic Plasticity in the Hippocampus: LTP and LTD. Cell 1994; 78: 535–538
   PubMed Web of Science ®Google Scholar
• Malenka R. C., Nicoll R. A. NMDA-Receptor-Dependent Synaptic Plasticity: Multiple Forms and Mechanisms. Trends Neurosci. 1993; 16: 521–527
   PubMedGoogle Scholar
• Rison R. A., Stanton P. K. Long-Term Potentiation and N-Methyl-D-Aspartate Receptors: Foundations of Memory and Neurologic Disease?. Neurosci. Biobehav. Rev. 1995; 19: 533–552
   PubMed Web of Science ®Google Scholar
• Choi D. W. Glutamate Receptors and the Induction of Excitotoxic Neuronal Death. Prog. Brain Res. 1994; 10047–10051
   Google Scholar
• Dingledine R., McBain C. J., McNamara J. O. Excitatory Amino Acid Receptors in Epilepsy. Trends Pharmacol. Sci. 1990; 11: 334–338
   PubMed Web of Science ®Google Scholar
• Olney J. W., Farber N. B. Glutamate Receptor Dysfunction and Schizophrenia. Arch. Gen. Psychiatry 1995; 52: 998–1007
   PubMed Web of Science ®Google Scholar
• Lipton S. A., Rosenberg P. A. Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders. N. Engl. J. Med. 1994; 330: 613–622
   PubMed Web of Science ®Google Scholar
• Bressan R. A., Pilowsky L. S. Imaging the Glutamatergic System In Vivo-Relevance to Schizophrenia. Eur. J. Nucl. Med. 2000; 27: 1723–1731
   PubMedGoogle Scholar
• Orita K., Sasaki S., Maeda M., Hashimoto A., Nishikawa T., Yugami T., Umezo K. Synthesis and Evaluation of 1-(1-[5-(2″-[18F]fluoroethyl)-2-thienyl]-cyclohexyl)piperidine as a Potential In Vivo Radioligand for the NMDA Receptor-Channel Complex. Nucl. Med. Biol. 1993; 20: 865–873
   PubMedGoogle Scholar
• Shibayama Y., Sasaki S., Tomita U., Nishikawa T., Maeda M. Synthesis and Evaluation of New 18F-Labelled thienylcyclohexylpiperidine (TCP) Analogues as Radioligands for the NMDA Receptor-Channel Complex. J. Lab. Compd. Radiopharm. 1996; 38: 77–86
   Google Scholar
• Ouyang X., Mukherjee J., Yang Z. Y. Synthesis, Radiosynthesis, and Biological Evaluation of Fluorinated Thienylcyclohexyl Piperidine Derivatives as Potential Radiotracers for the NMDA Receptor-Linked Calcium Ionophore. Nucl. Med. Biol. 1996; 23: 315–324
   PubMedGoogle Scholar
• Brown D. R., Wyper D. J., Owens J., Patterson J., Kelly R. C., Hunter R., McCulloch J. 123Iodo-MK-801: a Spect Agent for Imaging the Pattern and Extent of Glutamate (NMDA) Receptor Activation in Alzheimer's Disease. J. Psychiatr. Res. 1997; 31: 605–619
   PubMedGoogle Scholar
• Owens J., Wyper D. J., Patterson J., Brown D. R., Elliott A. T., Treasdale G. M, McCulloch J. First SPET Images of Glutamate (NMDA) Receptor Activation In Vivo in Cerebral Ischaemia. Nucl. Med. Commun. 1997; 18: 149–158
   PubMedGoogle Scholar
• Blin J., Denis A., Yamaguchi T., Crouzel C., MacKenzie E. T., Barron J. C. PET Studies of [18F]methyl-MK-801, a Potential NMDA Receptor Complex Radioligand. Neurosci. Lett. 1991; 121: 183–186
   PubMed Web of Science ®Google Scholar
• Sihver S., Sihver W., Andersson Y., Murata T., Bergström M., Onoe H., Matsumura K., Tsukata H., Oreland L., Langström B., Watanabe Y. In Vitro and In Vivo Characterization of (+)-3-[11C]cyano-dizocilpine. J. Neural. Transm. 1998; 105: 117–131
   PubMedGoogle Scholar
• Hartvig P., Valtysson J., Antoni G., Westerberg G., Langström B., Moberg E. R., Øye I. Brain Kinetics of (R)– and (S)–[N-methyl-11C]ketamine in the Rhesus Monkey Studied by Positron Emission Tomography (PET). Nucl. Med. Biol. 1994; 21: 927–934
   PubMed Web of Science ®Google Scholar
• Hartvig P., Valtysson J., Lindner K. J., Kristensen J., Karlsten R., Gustafson L. L., Persson J., Svensson J. O., Øye I., Antoni G. Central Nervous System Effects of Subdissociative Doses of (S)-ketamine are Related to Plasma and Brain Concentrations Measured with Positron Emission Tomography in Healthy Volunteers. Clin. Pharmacol. Ther. 1995; 58: 165–173
   PubMed Web of Science ®Google Scholar
• Shiue C. Y., Vallabhahosula S., Wolf A. P., Dewey S. L., Fowler J. S., Schlyer D. J., Arnett C. D., Zhou Y. G. Carbon-11 Labelled Ketamine-Synthesis, Distribution in Mice and PET Studies in Baboons. Nucl. Med. Biol. 1997; 24: 145–150
   PubMedGoogle Scholar
• Ametamey S. M., Samnick S., Leenders K. L., Vontobel P., Quack G., Parsons C.-G., Schubiger P. A. Fluorine-18 Radiolabelling, Biodistribution Studies and Preliminary PET Evaluation of a New Memantine Derivative for Imaging the NMDA Receptor. J. Recept. Signal Transduct. Res. 1999; 19: 129–141
   PubMed Web of Science ®Google Scholar
• Samnick S., Ametamey S., Leenders K. L., Vontobel P., Quack G., Parsons C.-G., Neu H., Schubiger P. A. Electrophysiological Study, Biodistribution in Mice, and Preliminary PET Evaluation in a Rhesus Monkey of 1-amino-3-[18F]fluoromethyl-5-methyl-adamantane (18F-MEM): a Potential Radioligand for Mapping the NMDA-Receptor Complex. Nucl. Med. Biol. 1998; 25: 323–330
   PubMed Web of Science ®Google Scholar
• Grauert M., Bechtel W. D., Ensinger H. A., Merz H., Carter A. J. Synthesis and Structure-Activity Relationships of 6,7-benzomorphane Derivatives as Antagonists of the NMDA Receptor-Channel complex. J. Med. Chem. 1997; 40: 2922–2930
   PubMedGoogle Scholar
• Grauert M., Rho J. M., Subramaniam S., Rogawski M. A. N-methyl-D-aspartate Receptor Channel Block by the Enantiomeric 6,7-benzomorphans BIII 277 CL and BIII 281 CL. J. Pharmacol. Exp. Ther. 1998; 285: 767–776
   PubMedGoogle Scholar
• Larsen P., Ulin J., Dahlstrom K. J. Lab. Compd. Radiopharm. 1995; 37: 73
   Google Scholar
• Link J. M., Krohn K. A., Clark J. C. Production of [11C]CH3I by Single Pass Reaction of [11C]CH4 with I2. Nucl. Med. Biol. 1997; 24: 93–97
   PubMedGoogle Scholar
• Mikolajczyk K., Szabatin M., Rudnicki P., Grodzki M., Burger C. A JAVA Environment for Medical Image Data Analysis: Initial Application for Brain PET Quantitation. Med. Inform. (Lond) 1998; 23: 207–214
   PubMed Web of Science ®Google Scholar
• Ametamey S., Vollenweider F. X., Patt J., Bourquin D., Hasler F., Beer H.-F, Schubiger P. A. C-11-Radiolabeling of Hallucinogenic Psilocin, a Potential Radioligand for Studying the Role of Serotonin Receptors in Psychotic Symptom Formation. J. Lab. Compd. Radiopharm. 1998; 41: 585–594
   Google Scholar